- Home
- SGHT vs BGT Comparison
SGHT vs BGT Comparison
Compare SGHT & BGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- BGT
- Stock Information
- Founded
- SGHT 2011
- BGT 2004
- Country
- SGHT United States
- BGT United States
- Employees
- SGHT N/A
- BGT N/A
- Industry
- SGHT Medical Specialities
- BGT Trusts Except Educational Religious and Charitable
- Sector
- SGHT Health Care
- BGT Finance
- Exchange
- SGHT Nasdaq
- BGT Nasdaq
- Market Cap
- SGHT 304.4M
- BGT 300.3M
- IPO Year
- SGHT 2021
- BGT N/A
- Fundamental
- Price
- SGHT $3.87
- BGT $13.23
- Analyst Decision
- SGHT Buy
- BGT
- Analyst Count
- SGHT 7
- BGT 0
- Target Price
- SGHT $6.58
- BGT N/A
- AVG Volume (30 Days)
- SGHT 242.2K
- BGT 107.2K
- Earning Date
- SGHT 11-07-2024
- BGT 01-01-0001
- Dividend Yield
- SGHT N/A
- BGT 10.77%
- EPS Growth
- SGHT N/A
- BGT N/A
- EPS
- SGHT N/A
- BGT N/A
- Revenue
- SGHT $79,543,000.00
- BGT N/A
- Revenue This Year
- SGHT $2.18
- BGT N/A
- Revenue Next Year
- SGHT $8.14
- BGT N/A
- P/E Ratio
- SGHT N/A
- BGT N/A
- Revenue Growth
- SGHT N/A
- BGT N/A
- 52 Week Low
- SGHT $2.58
- BGT $10.89
- 52 Week High
- SGHT $8.45
- BGT $13.42
- Technical
- Relative Strength Index (RSI)
- SGHT 39.20
- BGT 58.98
- Support Level
- SGHT $3.65
- BGT $13.07
- Resistance Level
- SGHT $4.11
- BGT $13.59
- Average True Range (ATR)
- SGHT 0.19
- BGT 0.18
- MACD
- SGHT 0.06
- BGT 0.03
- Stochastic Oscillator
- SGHT 27.50
- BGT 54.43
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About BGT BlackRock Floating Rate Income Trust
Blackrock Floating Rate Income Trust is a closed-end management investment company. Its investment objective is to provide a high level of current income. The company's secondary investment objective is to seek the preservation of capital. The Trust seeks to achieve its investment objectives by investing mainly, under normal conditions, at least 80% of its assets in floating and variable rate instruments of U.S. and non-U.S. issuers, including a substantial portion of its assets in floating and variable rate securities including senior secured floating rate loans made to corporate and other business entities.